+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Infectious Disease Diagnostics Market, By Technology, By Animal Type, By End-Users, By Region, Trend Analysis, Competitive Market Share & Forecast, 2018-2028

  • ID: 5585117
  • Report
  • March 2022
  • Region: Global
  • 230 Pages
  • Blueweave Consulting & Research Pvt Ltd

Global Veterinary Infectious Disease Diagnostics Market to Boost in Coming Years-Projected to Reach worth USD 2.636.8 Million in 2028


Rising technological advancement in diagnostic devices, automation, rising companion animal population, coupled with the increasing trend of pet insurance, is the key factor anticipated to propel the demand of the veterinary infectious disease diagnostics market in the forecast period.

This recent study revealed that the Global Veterinary Infectious Disease Diagnostics Market was worth USD 1,552.8 million in 2021 and is projected to reach up to USD 2.636.8 million by the year 2028, growing at a CAGR of 8.7 % over the analysis period of 2022-2028. Rising technical advancement in diagnostic instruments, automation, rising companion animal population, and the increasing trend of pet insurance are expected to drive demand for the veterinary infectious disease diagnostics market during the forecast period. Furthermore, rising investment in animal healthcare, rising zoonotic disease incidence, and rising disposable income in emerging nations would drive the worldwide veterinary infectious disease diagnostics market.

Increase in Incidence of Rabies Across Some Nations is driving the Global Veterinary Infectious Disease Diagnostics Market


There is a growing incidence of people getting infected with rabies worldwide. The disease, which has been found to have a 100% mortality rate, is rising. Dogs and bats happen to be the main source of human-led rabies deaths and contribute to more than 99% of all transmissions that were carried forward to humans.

According to the National Travel Health Network and Centre, By 2019, Over four imported rabies cases got reported across European travelers. In May 2019, Norway announced its confirmation for one rabies-related mortality, followed by an infection in the Philippines. In December 2019, over three fatalities associated with rabies were confirmed. Since rabies has been found to have an incubation period of 2-3 months, it spreads slowly but reduces the chances for that particular infected human to survive. As a result, these cases have spurred a growing demand for diagnosis and disease prevention across some nations, positively impacting the growth of the infectious disease diagnostics market.

Higher costs across some middle- and low-income nations are hindering the growth of the Global Veterinary Infectious Disease Diagnostics Market


Although the number of pet ownership has been on the rise, there is an equal if not a better upward trend in the costs associated with the veterinary treatment of domesticated animals. Some of the primary services offered by vets include clinical services (treatment-related to diseased animals and controlling production), preventive services (averting any disease outbreak), provision of drugs, vaccines, and other pharmaceuticals, and human health protection (comprising inspection of animal products). Such high costs with some amounting close to the annual per capita of some middle and low-income countries demonstrate the higher costs of veterinary service prices around the world, which have kept the diagnostic test and routine checkup of animals out of the picture for a long time, negatively contributing to the demand of veterinary infectious disease diagnostics, thereby hindering the growth of the market.

Impact Of COVID-19 On The Global Veterinary Infectious Disease Diagnostics Market


The advent of newer biotechnological techniques, including gene cloning, immunohistochemistry procedures, and immunogen overexpression assays, has demonstrated that it is becoming increasingly possible to generate specific spike proteins, which could revolutionize the present generation of immunoassays. The techniques could augment the sensitivity and specificity capabilities of assays by offering an improved antibody binding target and reducing volatility found across intra-kit incorporation. For instance, In April 2020, IDEXX Laboratories, Inc. announced that the company is making its IDEXX SARS-CoV-2 RealPCR™ Test available for pets. IDEXX stated that they were launching the test regarding the growing customer demand and evidence found across pets living with COVID-19 positive owners. The test was only made available for veterinarians across the North American region; however, it was made available to the rest of the world in the next few months.

Europe is Growing at a Significant Rate in The Global Veterinary Infectious Disease Diagnostics Market.

In terms of regional analysis global veterinary infectious disease diagnostics market is classified into North America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa. The growing number of Zoonoses in the region, rising awareness towards regular checkups of poultry and pets, and growing penetration of animal insurances has supported the growth of the veterinary infectious disease diagnostics market in the European region. Additionally, the support from the government to control the frequent outbreaks of veterinary infectious disease in the region has further supported the growth of the market. The advancements in the ELISE tests and PCR tests is expected to present growth opportunities during the forecast period.

Competitive Landscape


The Global Veterinary Infectious Disease Diagnostics Market is characterized by the presence of many local, regional, and global vendors. The market for veterinary infectious disease diagnostics is partially consolidated, with fierce competition among the leading players. The leading market players of the global veterinary infectious disease diagnostics market are Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, Boehringer Ingelheim Vetmedica, Inc., Dechra Pharmaceuticals PLC, Ceva Santé Animale, Bayer AG, Vetoquinol S.A, HESKA Corporation, Demeditec Diagnostics GmbH, and other prominent players.

Don’t miss the business opportunity of the Global Veterinary Infectious Disease Diagnostics Market. Consult the report to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Veterinary Infectious Disease Diagnostics Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Veterinary Infectious Disease Diagnostics Market¬, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the market's growth drivers, challenges, and competitive dynamics.


This product will be delivered within 2 business days.

Table of Contents

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Veterinary Infectious Disease Diagnostics Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Veterinary Infectious Disease Diagnostics Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.1.1. Immunodiagnostics
5.2.1.1.1. Lateral Flow Assays
5.2.1.1.2. ELISA Tests
5.2.1.1.3. Other Immunodiagnostic Technologies
5.2.1.2. Molecular Diagnostics
5.2.1.2.1. Polymerase Chain Reaction (PCR) Tests
5.2.1.2.2. Microarrays
5.2.1.2.3. Other Molecular Diagnostic Tests
5.2.1.3. Others
5.2.2. By Animal Type
5.2.2.1. Companion Animals
5.2.2.2. Food Producing Animals
5.2.3. By End-User
5.2.3.1. Reference Laboratories
5.2.3.2. Veterinary Hospitals and Clinics
5.2.3.3. Point of Care/In House Testing
5.2.3.4. Research Institutes and Universities
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. The Asia Pacific
5.2.4.4. Latin America
5.2.4.5. The Middle East and Africa
6. North America Veterinary Infectious Disease Diagnostics Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Animal Type
6.2.3. By End-User
6.2.4. By Country
6.2.4.1. United States
6.2.4.2. Canada
7. Europe Veterinary Infectious Disease Diagnostics Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Animal Type
7.2.3. By End-User
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. United Kingdom
7.2.4.3. Italy
7.2.4.4. France
7.2.4.5. Spain
7.2.4.6. Rest of Europe
8. The Asia Pacific Veterinary Infectious Disease Diagnostics Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Animal Type
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. South Korea
8.2.4.5. Rest of Asia Pacific
9. Latin America Veterinary Infectious Disease Diagnostics Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Animal Type
9.2.3. By End-User
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Mexico
9.2.4.3. Rest of Latin America
10. The Middle East & Africa Global Veterinary Infectious Disease Diagnostics Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Animal Type
10.2.3. By End-User
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of COVID-19 on Global Veterinary Infectious Disease Diagnostics Market Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. Biomerieux S.A.
13.2. Innovative Diagnostics
13.3. IDEXX Laboratories, Inc.
13.4. Neogen Corporation
13.5. QIAGEN N.V.
13.6. Randox Laboratories, Ltd.
13.7. Thermo Fisher Scientific
13.8. Virbac
13.9. Zoetis, Inc.
13.10. Elanco
13.11. Merck & Co. Inc
13.12. Boehringer Ingelheim Vetmedica, Inc.
13.13. Bayer AG
13.14. HESKA Corporation
13.15. Demeditec Diagnostics GmbH
13.16. Other Prominent Players
14. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
Figure 1 Global Veterinary Infectious Disease Diagnostics Segmentation
Figure 2 Global Veterinary Infectious Disease Diagnostics Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2021
Figure 4 Global Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2018-2028
Figure 5 Global Veterinary Infectious Disease Diagnostics Market Share, By Technology, By Value, 2018-2028
Figure 6 Global Veterinary Infectious Disease Diagnostics Market Share, By Animal Type, By Value, 2018-2028
Figure 7 Global Veterinary Infectious Disease Diagnostics Market Share, By End-User, By Value, 2018-2028
Figure 8 Global Veterinary Infectious Disease Diagnostics Market Share, By Region, By Value, 2018-2028
Figure 9 North America Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2018-2028
Figure 10 North America Veterinary Infectious Disease Diagnostics Market Share, By Technology, By Value, 2018-2028
Figure 11 North America Veterinary Infectious Disease Diagnostics Market Share, By Animal Type, By Value, 2018-2028
Figure 12 North America Veterinary Infectious Disease Diagnostics Market Share, By End-User, By Value, 2018-2028
Figure 13 North America Veterinary Infectious Disease Diagnostics Market Share, By Country, By Value, 2018-2028
Figure 14 Europe Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2018-2028
Figure 15 Europe Veterinary Infectious Disease Diagnostics Market Share, By Technology, By Value, 2018-2028
Figure 16 Europe Veterinary Infectious Disease Diagnostics Market Share, By Animal Type, By Value, 2018-2028
Figure 17 Europe Veterinary Infectious Disease Diagnostics Market Share, By End-User, By Value, 2018-2028
Figure 18 Europe Veterinary Infectious Disease Diagnostics Market Share, By Country, By Value, 2018-2028
Figure 19 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2018-2028
Figure 20 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share, By Technology, By Value, 2018-2028
Figure 21 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share, By Animal Type, By Value, 2018-2028
Figure 22 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share, By End-User, By Value, 2018-2028
Figure 23 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share, By Country, By Value, 2018-2028
Figure 24 Latin America Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2018-2028
Figure 25 Latin America Veterinary Infectious Disease Diagnostics Market Share, By Technology, By Value, 2018-2028
Figure 26 Latin America Veterinary Infectious Disease Diagnostics Market Share, By Animal Type, By Value, 2018-2028
Figure 27 Latin America Veterinary Infectious Disease Diagnostics Market Share, By End-User, By Value, 2018-2028
Figure 28 Latin America Veterinary Infectious Disease Diagnostics Market Share, By Country, By Value, 2018-2028
Figure 29 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2018-2028
Figure 30 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share, By Technology, By Value, 2018-2028
Figure 31 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share, By Animal Type, By Value, 2018-2028
Figure 32 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share, By End-User, By Value, 2018-2028
Figure 33 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share, By Country, By Value, 2018-2028
List of Tables
Table 1 Global Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value, 2018-2028
Table 2 Global Veterinary Infectious Disease Diagnostics Market Size, By Animal Type, By Value, 2018-2028
Table 3 Global Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value, 2018-2028
Table 4 Global Veterinary Infectious Disease Diagnostics Market Size, By Region, By Value, 2018-2028
Table 5 North America Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value, 2018-2028
Table 6 North America Veterinary Infectious Disease Diagnostics Market Size, By Animal Type, By Value, 2018-2028
Table 7 North America Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value, 2018-2028
Table 8 North America Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value, 2018-2028
Table 9 Europe Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value, 2018-2028
Table 10 Europe Veterinary Infectious Disease Diagnostics Market Size, By Animal Type, By Value, 2018-2028
Table 11 Europe Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value, 2018-2028
Table 12 Europe Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value, 2018-2028
Table 13 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value, 2018-2028
Table 14 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Animal Type, By Value, 2018-2028
Table 15 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value, 2018-2028
Table 16 The Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value, 2018-2028
Table 17 Latin America Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value, 2018-2028
Table 18 Latin America Veterinary Infectious Disease Diagnostics Market Size, By Animal Type, By Value, 2018-2028
Table 19 Latin America Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value, 2018-2028
Table 20 Latin America Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value, 2018-2028
Table 21 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value, 2018-2028
Table 22 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Animal Type, By Value, 2018-2028
Table 23 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value, 2018-2028
Table 24 The Middle East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value, 2018-2028
Table 25 Biomerieux S.A. Company Overview
Table 26 Biomerieux S.A. Financial Overview
Table 27 Heska Corporation Company Overview
Table 28 Heska Corporation Financial Overview
Table 29 Neogen Corporation Company Overview
Table 30 Neogen Corporation Financial Overview
Table 31 QIAGEN N.V. Company Overview
Table 32 QIAGEN N.V. Financial Overview
Table 33 Thermo Fisher Scientific Company Overview
Table 34 Thermo Fisher Scientific Financial Overview
Table 35 Zoetis, Inc. Company Overview
Table 36 Zoetis, Inc. Financial Overview
Table 37 Elanco Company Overview
Table 38 Elanco Financial Overview
Table 39 Merck & Co. Inc Company Overview
Table 40 Merck & Co. Inc Financial Overview
Table 41 Bayer AG Company Overview
Table 42 Bayer AG Financial Overview
Table 43 HESKA Corporation Company Overview
Table 44 HESKA Corporation Financial Overview
Table 45 Demeditec Diagnostics GmbH Company Overview
Table 46 Demeditec Diagnostics GmbH Financial Overview
Table 47 IDEXX Laboratories, Inc. Company Overview
Table 48 IDEXX Laboratories, Inc. Financial Overview
Table 49 Randox Laboratories, Ltd. Company Overview
Table 50 Randox Laboratories, Ltd. Financial Overview
Table 51 Virbac Company Overview
Table 52 Virbac Financial Overview
Table 53 Boehringer Ingelheim Vetmedica, Inc. Company Overview
Table 54 Boehringer Ingelheim Vetmedica, Inc. Financial Overview
Table 55 Innovative Diagnostics Company Overview
Table 56 Innovative Diagnostics Financial Overview

Methodology

Loading
LOADING...